Business Information
The company's principal activity is to develop, manufacture and market heart-monitoring devices. These devices provide medical professionals with continuous data on a range of parameters relating to blood flow and heart function. The technology noninvasively monitors the heart's ability to deliver blood to the body and the amount of fluid in the chest. The technology provides the medical professionals in the hospital to effectively assess, diagnose and treat congestive heart failure and hypertension and to evaluate emergency, pacemaker and dialysis patients. The company's primary products include bioz(R) icg monitor, bioztect(R) sensors, bioz(R) icg module, bioz.sim(R) icg simulator, bioz(R) system and bioz.PC system.
|
|
Name |
Title
|
Email
|
| James Gilstrap | Chmn. | N/A | | Rhonda Rhyne | Pres. | N/A | | Donald Brooks | Pres. - Product Development, CTO | N/A | | Richard Trayler | COO, VP - International Operations | N/A | | Paul Jansen | VP - Clinical, Marketing Development | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 30,342 | (6,694) | | 2005 | 37,005 | (14,945) | | 2004 | 40,988 | 10,123
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
